Attributable risk of hospital admissions for overall and specific mental disorders due to particulate matter pollution: A time-series study in Chengdu, China.

The associations of particulate matter (PM) pollution with the morbidity of overall and subtypes of mental disorders (MDs), as well as the corresponding morbidity burden, remain understudied, especially in developing countries. This study aimed to evaluate the short-term effects of PM2.5 (diameters ≤ 2.5 µm), PM10 (diameters ≤ 10 µm) and PMC (diameters between 2.5 and 10 µm) on hospital admissions (HAs) for MDs in Chengdu, China, during 2015-2016, and calculate corresponding attributable risks. A generalized additive model (GAM) with controlling for time trend, meteorological conditions, holidays and day of the week was used to estimate the associations. Stratified analyses were also performed by age, gender and season. We further estimated the burden of HAs for MDs attributable to PM exposure. During the study period, a total of 10,947 HAs for MDs were collected. PM2.5, PM10 and PMC were significantly associated with elevated risks of MDs hospitalizations. Each 10 μg/m3 increase in PM2.5, PM10 and PMC at lag06 corresponded to an increase of 2.89% (95% CI: 0.75-5.08%), 1.91% (95% CI: 0.57-3.28%) and 3.95% (95% CI: 0.84-7.15%) in daily HAs for MDs, respectively. The risk estimates of PM on MDs hospitalizations were generally robust after adjustment for gaseous pollutants in two-pollutant models. We found stronger associations between PM pollution and MDs in males and in cool seasons than in females and in warm seasons. For specific subtypes of MDs, significant associations of PM pollution with dementia,schizophrenia and depression were observed. Using WHO's air quality guidelines as the reference concentrations, 9.53% (95% CI: 2.67-15.58%), 9.17% (95% CI: 2.91-14.70%) and 6.10% (95% CI: 1.40-10.32%) of HAs for MDs could be attributable to PM2.5, PM10 and PMC, respectively. Our results suggested that PM exposure might be an important trigger of hospitalizations for MDs in Chengdu, China, and account for substantial morbidity burden.